# MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

> **NCT03699995** · NA · TERMINATED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 17 (actual)

## Conditions studied

- Cutaneous Melanoma
- Melanocytic Nevus
- Skin Carcinoma

## Interventions

- **OTHER:** Confocal Microscopy
- **OTHER:** Dermoscopy
- **PROCEDURE:** Imaging Procedure
- **DRUG:** Lidocaine
- **PROCEDURE:** Punch Biopsy
- **PROCEDURE:** Shave Biopsy

## Key facts

- **NCT ID:** NCT03699995
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-18
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** The study did not meet its accrual goals due to the departure of study personnel. Study team opted for a study closure due to loss of key personnel.
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03699995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03699995, "MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03699995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*